Results 201 to 210 of about 89,708 (258)

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Anal Cancer Incidence Among Women With a History of Cervical Cancer by Age and Time Since Diagnosis.

open access: yesJAMA Netw Open
Damgacioglu H   +7 more
europepmc   +1 more source

Anal Cancer and Anal Cancer Screening

Clinical Obstetrics & Gynecology, 2023
This chapter provides an overview of anal cancer and contemporary approaches for anal precancer detection, beginning with a discussion of the biology and natural history of anal squamous cell carcinoma, the predominant human papillomavirus -associated histologic subtype of anal cancer.
Camryn M. Cohen, Megan A. Clarke
openaire   +2 more sources

Anal Cancer

Surgical Clinics of North America, 2020
Anal cancer is a rare cancer, comprising less than 5% of gastrointestinal tract malignancies. Diagnosis of anal canal cancer can be difficult given that presenting symptoms are similar to those of benign anorectal diseases. General surgeons who encounter suspected anal canal cancer need to have a good understanding of the anatomy of the anal canal ...
Anne N, Young   +5 more
openaire   +3 more sources

Benign Anal Lesions and Anal Cancer

New England Journal of Medicine, 1995
To the Editor: Frisch et al. (Aug. 4 issue)1 examined the association between benign anal lesions and the risk of anal cancer.
A Y, Lin, G, Gridley, M, Tucker
openaire   +2 more sources

Anal Cancer

Surgical Oncology Clinics of North America
Abstract This chapter outlines the epidemiology, aetiology, pathology, and metastatic patterns of anal cancer. It includes guides to symptoms, diagnosis, staging, and planning therapy. It outlines surgical, radiotherapy, and chemotherapy options for both early-stage and metastatic disease.
Katherine R. Amarell   +2 more
  +5 more sources

Immunotherapy in Anal Cancer

Current Oncology Reports, 2020
Standard treatment for early-stage squamous cell cancer of the anal canal (SCCA) includes concurrent chemotherapy and radiation to achieve curative intent. Treatment options are limited, however, especially with locoregional disease relapse occurring in 20-30% of patients and about 10-30% of patients presenting with metastatic disease.
Lisa Phuong, Lakshmi Rajdev
openaire   +2 more sources

Cancer of the anal region

Critical Reviews in Oncology/Hematology, 2002
Cancer of the anal region represents 3-3.5% of all anorectal tumours. The peak incidence is between 58 and 64 years. Since 1960 an increased incidence among men younger than 45 years, and among women has been observed. The number of women diagnosed with anal canal cancer (7 per 1,000,000 person per years) is twice as much as that of men, while anal ...
Licitra, L.   +5 more
openaire   +2 more sources

The epidemiology of anal cancer

Sexual Health, 2012
Anal cancer comprises malignancies of the anal canal principally of two morphologic variants: squamous cell carcinoma (SCC) and adenocarcinoma. In most settings, SCC compromises more than 70% of cases. In the general population, anal cancer is uncommon, with age-standardised incidence rates mostly between 1 and 2 per 100 000 per year.
Andrew E, Grulich   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy